Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-25
DOI
10.1038/s41375-019-0446-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic lymphocytic leukaemia
- (2017) Thomas J. Kipps et al. Nature Reviews Disease Primers
- An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
- (2016) LANCET ONCOLOGY
- Telomere and Telomerase Therapeutics in Cancer
- (2016) Yucheng Xu et al. Genes
- Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
- (2015) K. Fischer et al. BLOOD
- Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
- (2015) Philip A. Thompson et al. CANCER
- Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian
- (2015) Hongkun Wang et al. CARCINOGENESIS
- Telomere length, genetic variants and gastric cancer risk in a Chinese population
- (2015) Jiangbo Du et al. CARCINOGENESIS
- Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
- (2015) Chenan Zhang et al. HUMAN MOLECULAR GENETICS
- Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
- (2015) J C Strefford et al. LEUKEMIA
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- Prognostic markers and standard management of chronic lymphocytic leukemia
- (2015) S. Stilgenbauer Hematology-American Society of Hematology Education Program
- Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
- (2014) S. Stilgenbauer et al. BLOOD
- Longer Telomeres Are Associated with Cancer Risk in MMR-Proficient Hereditary Non-Polyposis Colorectal Cancer
- (2014) Nuria Seguí et al. PLoS One
- The Association of Telomere Length with Colorectal Cancer Differs by the Age of Cancer Onset
- (2014) Lisa A Boardman et al. Clinical and Translational Gastroenterology
- Toward a Molecular Classification of Colorectal Cancer: The Role of Telomere Length
- (2014) Esha Baichoo et al. Frontiers in Oncology
- The Role of Telomere Biology in Cancer
- (2012) Lifeng Xu et al. Annual Review of Pathology-Mechanisms of Disease
- High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
- (2012) J. Edelmann et al. BLOOD
- Cellular origin and pathophysiology of chronic lymphocytic leukemia
- (2012) Marc Seifert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes
- (2011) E. Rampazzo et al. HAEMATOLOGICA
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Telomere length as a biological marker in malignancy
- (2009) Ulrika Svenson et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Telomere Diseases
- (2009) Rodrigo T. Calado et al. NEW ENGLAND JOURNAL OF MEDICINE
- A quantitative real-time PCR method for absolute telomere length
- (2008) Nathan J. O'Callaghan et al. BIOTECHNIQUES
- Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+chronic lymphocytic leukaemia
- (2008) Alexander Röth et al. BRITISH JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started